METHOD OF RESEARCH
SUBJECT OF RESEARCH
CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation
ARTICLE PUBLICATION DATE
Disclosures: M. Boieri is an employee of Zelluna Immunotherapy. S. Iyer is an employee of and has equity in Verve Therapeutics. M.N. Rivera reported grants from Advanced Cell Diagnostics and non-financial support from Merck/Serono outside the submitted work. No other disclosures were reported.